HEADER HYDROLASE 11-NOV-05 2C6P TITLE MEMBRANE-BOUND GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH TITLE 2 PHOSPHATE ANION COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUTAMATE CARBOXYPEPTIDASE II; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MEMBRANE GLUTAMATE CARBOXYPEPTIDASE, MGCP, N-ACETYLATED- COMPND 5 ALPHA-LINKED ACIDIC DIPEPTIDASE I, NAALADASE I, PTEROYLPOLY-GAMMA- COMPND 6 GLUTAMATE CARBOXYPEPTIDASE, FOLYLPOLY-GAMMA-GLUTAMATE COMPND 7 CARBOXYPEPTIDASE, FGCP, FOLATE HYDROLASE 1, PROSTATE-SPECIFIC COMPND 8 MEMBRANE ANTIGEN, PSMA, PSM; COMPND 9 EC: 3.4.17.21; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: BRAIN; SOURCE 6 EXPRESSION_SYSTEM: DROSOPHILA MELANOGASTER; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7227; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SCHNEIDER'S CELLS KEYWDS NAALADASE, NEURODEGENERATIVE DISEASE, PEPTIDASE, PROSTATE CANCER, KEYWDS 2 PSMA, GLYCOPROTEIN, HYDROLASE, ALTERNATIVE SPLICING, ANTIGEN, KEYWDS 3 CARBOXYPEPTIDASE, DIPEPTIDASE, METAL-BINDING, METALLOPROTEASE, KEYWDS 4 MULTIFUNCTIONAL ENZYME, POLYMORPHISM, SIGNAL-ANCHOR, TRANSMEMBRANE, KEYWDS 5 ZINC EXPDTA X-RAY DIFFRACTION AUTHOR J.R.MESTERS,C.BARINKA,W.LI,T.TSUKAMOTO,P.MAJER,B.S.SLUSHER, AUTHOR 2 J.KONVALINKA,R.HILGENFELD REVDAT 6 29-JUL-20 2C6P 1 COMPND REMARK HETNAM LINK REVDAT 6 2 1 SITE ATOM REVDAT 5 18-SEP-19 2C6P 1 REMARK REVDAT 4 24-JUL-19 2C6P 1 REMARK LINK REVDAT 3 24-FEB-09 2C6P 1 VERSN REVDAT 2 14-DEC-06 2C6P 1 JRNL REVDAT 1 15-FEB-06 2C6P 0 JRNL AUTH J.R.MESTERS,C.BARINKA,W.LI,T.TSUKAMOTO,P.MAJER,B.S.SLUSHER, JRNL AUTH 2 J.KONVALINKA,R.HILGENFELD JRNL TITL STRUCTURE OF GLUTAMATE CARBOXYPEPTIDASE II, A DRUG TARGET IN JRNL TITL 2 NEURONAL DAMAGE AND PROSTATE CANCER. JRNL REF EMBO J. V. 25 1375 2006 JRNL REFN ISSN 0261-4189 JRNL PMID 16467855 JRNL DOI 10.1038/SJ.EMBOJ.7600969 REMARK 2 REMARK 2 RESOLUTION. 2.39 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.39 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.14 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 3 NUMBER OF REFLECTIONS : 40228 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.600 REMARK 3 FREE R VALUE TEST SET COUNT : 1067 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.39 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.46 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2318 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3050 REMARK 3 BIN FREE R VALUE SET COUNT : 54 REMARK 3 BIN FREE R VALUE : 0.3960 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5155 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 132 REMARK 3 SOLVENT ATOMS : 87 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.43 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.98000 REMARK 3 B22 (A**2) : -2.73000 REMARK 3 B33 (A**2) : 1.74000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.259 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.223 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.162 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.299 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.919 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5436 ; 0.016 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 4695 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7400 ; 1.714 ; 1.973 REMARK 3 BOND ANGLES OTHERS (DEGREES): 10824 ; 0.944 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 673 ; 7.447 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 789 ; 0.102 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6114 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1141 ; 0.004 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1189 ; 0.227 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 5405 ; 0.242 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 3044 ; 0.091 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 138 ; 0.152 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 14 ; 0.165 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 51 ; 0.246 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 10 ; 0.341 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3350 ; 0.883 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5351 ; 1.652 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2086 ; 2.122 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2049 ; 3.659 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2C6P COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-NOV-05. REMARK 100 THE DEPOSITION ID IS D_1290026324. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-DEC-03 REMARK 200 TEMPERATURE (KELVIN) : 261.0 REMARK 200 PH : 7.25 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X13 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.803 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42414 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 47.140 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20 MM HEPES PH 7.25, 200 MM NACL, 5% REMARK 280 (W/V) PEG 400 AND 15% (W/V) PEG 1500 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 51.28650 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 65.18250 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 79.70700 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 51.28650 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 65.18250 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 79.70700 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 51.28650 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 65.18250 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 79.70700 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 51.28650 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 65.18250 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 79.70700 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 130.36500 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2063 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 44 REMARK 465 SER A 45 REMARK 465 SER A 46 REMARK 465 ASN A 47 REMARK 465 GLU A 48 REMARK 465 ALA A 49 REMARK 465 THR A 50 REMARK 465 ASN A 51 REMARK 465 ILE A 52 REMARK 465 THR A 53 REMARK 465 PRO A 54 REMARK 465 LYS A 55 REMARK 465 HIS A 56 REMARK 465 THR A 334 REMARK 465 GLY A 335 REMARK 465 ASN A 336 REMARK 465 PHE A 337 REMARK 465 SER A 338 REMARK 465 THR A 339 REMARK 465 GLN A 340 REMARK 465 LYS A 341 REMARK 465 TRP A 541 REMARK 465 GLU A 542 REMARK 465 THR A 543 REMARK 465 ASN A 544 REMARK 465 LYS A 545 REMARK 465 PHE A 546 REMARK 465 SER A 547 REMARK 465 LYS A 655 REMARK 465 SER A 656 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 59 CD CE NZ REMARK 470 LYS A 72 CD CE NZ REMARK 470 GLU A 87 OE1 OE2 REMARK 470 GLN A 91 OE1 NE2 REMARK 470 LYS A 94 CE NZ REMARK 470 LYS A 101 CD CE NZ REMARK 470 GLU A 102 CD OE1 OE2 REMARK 470 LYS A 122 CE NZ REMARK 470 HIS A 124 ND1 CD2 CE1 NE2 REMARK 470 ILE A 128 CG1 CG2 CD1 REMARK 470 ILE A 130 CD1 REMARK 470 GLU A 133 CB CG CD OE1 OE2 REMARK 470 ASP A 134 CB CG OD1 OD2 REMARK 470 ASN A 136 CG OD1 ND2 REMARK 470 ILE A 138 CG2 CD1 REMARK 470 PHE A 139 CD1 CD2 CE1 CE2 CZ REMARK 470 PHE A 144 CD1 CD2 CE1 CE2 CZ REMARK 470 GLU A 152 CB CG CD OE1 OE2 REMARK 470 VAL A 154 CB CG1 CG2 REMARK 470 SER A 155 CB OG REMARK 470 ASP A 173 CB CG OD1 OD2 REMARK 470 LEU A 174 CB CG CD1 CD2 REMARK 470 GLU A 183 CG CD OE1 OE2 REMARK 470 LYS A 187 CB CG CD CE NZ REMARK 470 LEU A 188 CD1 CD2 REMARK 470 GLU A 189 CB CG CD OE1 OE2 REMARK 470 ARG A 190 CB CG CD NE CZ NH1 NH2 REMARK 470 LYS A 193 CG CD CE NZ REMARK 470 ILE A 194 CG1 CG2 CD1 REMARK 470 ASN A 195 CG OD1 ND2 REMARK 470 SER A 197 CB OG REMARK 470 LYS A 199 CG CD CE NZ REMARK 470 LYS A 207 CD CE NZ REMARK 470 LYS A 215 CD CE NZ REMARK 470 LEU A 219 CD1 CD2 REMARK 470 LYS A 223 CD CE NZ REMARK 470 ILE A 226 CD1 REMARK 470 LYS A 240 CG CD CE NZ REMARK 470 ILE A 283 CD1 REMARK 470 GLN A 303 CB CG CD OE1 NE2 REMARK 470 LYS A 304 CD CE NZ REMARK 470 LEU A 305 CB CG CD1 CD2 REMARK 470 LEU A 306 CD1 CD2 REMARK 470 LYS A 308 CG CD CE NZ REMARK 470 MET A 309 CB CG SD CE REMARK 470 SER A 312 OG REMARK 470 ALA A 313 CB REMARK 470 SER A 317 CB OG REMARK 470 ARG A 320 CB CG CD NE CZ NH1 NH2 REMARK 470 LYS A 324 CD CE NZ REMARK 470 VAL A 325 CG2 REMARK 470 VAL A 329 CG1 CG2 REMARK 470 LYS A 343 CE NZ REMARK 470 HIS A 345 ND1 CD2 CE1 NE2 REMARK 470 ARG A 363 CD NE CZ NH1 NH2 REMARK 470 GLU A 480 OE1 OE2 REMARK 470 LYS A 482 CE NZ REMARK 470 GLU A 486 CD OE1 OE2 REMARK 470 LYS A 491 CE NZ REMARK 470 GLU A 495 CB CG CD OE1 OE2 REMARK 470 LYS A 499 CG CD CE NZ REMARK 470 GLU A 505 CB CG CD OE1 OE2 REMARK 470 PHE A 506 CB CG CD1 CD2 CE1 CE2 CZ REMARK 470 SER A 507 CB OG REMARK 470 ARG A 536 NE CZ NH1 NH2 REMARK 470 LYS A 539 CE NZ REMARK 470 MET A 569 CE REMARK 470 LYS A 606 CD CE NZ REMARK 470 LYS A 610 CD CE NZ REMARK 470 LYS A 617 CE NZ REMARK 470 LYS A 645 CD CE NZ REMARK 470 LYS A 718 CD CE NZ REMARK 470 LYS A 723 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 C ASP A 654 O HOH A 2059 2.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 2020 O HOH A 2083 2565 2.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ILE A 202 N - CA - C ANGL. DEV. = 18.5 DEGREES REMARK 500 ASP A 233 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 ASP A 301 CB - CG - OD2 ANGL. DEV. = 6.0 DEGREES REMARK 500 ASP A 316 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 ASP A 369 CB - CG - OD2 ANGL. DEV. = 6.3 DEGREES REMARK 500 ARG A 370 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 ASP A 599 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 ARG A 662 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 ARG A 688 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 124 66.27 -118.52 REMARK 500 PRO A 125 155.15 -44.26 REMARK 500 ILE A 138 -70.90 -69.07 REMARK 500 ASP A 156 39.87 72.92 REMARK 500 PHE A 164 6.22 86.69 REMARK 500 MET A 169 40.53 -144.73 REMARK 500 ASN A 178 -132.60 63.10 REMARK 500 LYS A 193 33.13 38.31 REMARK 500 SER A 197 108.09 -39.02 REMARK 500 ILE A 202 110.67 16.15 REMARK 500 LYS A 207 -64.28 74.36 REMARK 500 ALA A 222 154.51 -46.25 REMARK 500 LYS A 308 20.69 -78.84 REMARK 500 HIS A 347 -26.28 141.54 REMARK 500 VAL A 382 -105.49 -127.95 REMARK 500 ILE A 386 -60.68 -93.41 REMARK 500 GLU A 408 26.08 -79.38 REMARK 500 ALA A 452 60.04 -154.69 REMARK 500 SER A 454 117.48 -28.65 REMARK 500 PHE A 488 24.41 -146.64 REMARK 500 SER A 501 73.28 -157.87 REMARK 500 PHE A 506 141.16 79.35 REMARK 500 SER A 507 -99.74 -134.76 REMARK 500 ASP A 567 71.04 -159.41 REMARK 500 ASN A 589 -30.42 -130.53 REMARK 500 ALA A 693 124.64 116.83 REMARK 500 HIS A 697 -105.18 -97.77 REMARK 500 ASN A 698 78.27 -48.36 REMARK 500 TYR A 700 94.00 3.91 REMARK 500 ALA A 701 -23.34 156.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 VAL A 201 ILE A 202 41.13 REMARK 500 ILE A 346 HIS A 347 -58.80 REMARK 500 LYS A 699 TYR A 700 -147.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A1753 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 THR A 269 OG1 REMARK 620 2 THR A 269 O 74.7 REMARK 620 3 TYR A 272 O 93.4 73.2 REMARK 620 4 GLU A 433 OE2 100.9 150.9 135.8 REMARK 620 5 GLU A 433 OE1 92.5 153.0 84.2 53.9 REMARK 620 6 GLU A 436 OE2 167.6 98.4 74.5 90.1 89.4 REMARK 620 7 HOH A2011 O 93.6 73.4 142.6 78.3 132.1 94.3 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1752 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 377 NE2 REMARK 620 2 ASP A 387 OD1 108.5 REMARK 620 3 ASP A 453 OD1 100.4 86.6 REMARK 620 4 ASP A 453 OD2 109.8 127.1 51.8 REMARK 620 5 PO4 A1764 O1 98.2 115.0 145.0 94.0 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1751 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 387 OD2 REMARK 620 2 GLU A 425 OE1 156.0 REMARK 620 3 GLU A 425 OE2 96.1 60.1 REMARK 620 4 HIS A 553 NE2 102.9 82.9 106.6 REMARK 620 5 PO4 A1764 O3 109.3 92.8 140.8 96.5 REMARK 620 N 1 2 3 4 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1Z8L RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN, ATUMOR REMARK 900 MARKER AND PEPTIDASE REMARK 900 RELATED ID: 2C6C RELATED DB: PDB REMARK 900 MEMBRANE-BOUND GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX REMARK 900 WITH GPI-18431 (S)-2- (4-IODOBENZYLPHOSPHONOMETHYL)-PENTANEDIOIC REMARK 900 ACID REMARK 900 RELATED ID: 2C6G RELATED DB: PDB REMARK 900 MEMBRANE-BOUND GLUTAMATE CARBOXYPEPTIDASE II (GCPII) WITH BOUND REMARK 900 GLUTAMATE REMARK 999 REMARK 999 SEQUENCE REMARK 999 AMINO ACIDS 44-750 DBREF 2C6P A 44 750 UNP Q04609 FOLH1_HUMAN 44 750 SEQRES 1 A 707 LYS SER SER ASN GLU ALA THR ASN ILE THR PRO LYS HIS SEQRES 2 A 707 ASN MET LYS ALA PHE LEU ASP GLU LEU LYS ALA GLU ASN SEQRES 3 A 707 ILE LYS LYS PHE LEU TYR ASN PHE THR GLN ILE PRO HIS SEQRES 4 A 707 LEU ALA GLY THR GLU GLN ASN PHE GLN LEU ALA LYS GLN SEQRES 5 A 707 ILE GLN SER GLN TRP LYS GLU PHE GLY LEU ASP SER VAL SEQRES 6 A 707 GLU LEU ALA HIS TYR ASP VAL LEU LEU SER TYR PRO ASN SEQRES 7 A 707 LYS THR HIS PRO ASN TYR ILE SER ILE ILE ASN GLU ASP SEQRES 8 A 707 GLY ASN GLU ILE PHE ASN THR SER LEU PHE GLU PRO PRO SEQRES 9 A 707 PRO PRO GLY TYR GLU ASN VAL SER ASP ILE VAL PRO PRO SEQRES 10 A 707 PHE SER ALA PHE SER PRO GLN GLY MET PRO GLU GLY ASP SEQRES 11 A 707 LEU VAL TYR VAL ASN TYR ALA ARG THR GLU ASP PHE PHE SEQRES 12 A 707 LYS LEU GLU ARG ASP MET LYS ILE ASN CYS SER GLY LYS SEQRES 13 A 707 ILE VAL ILE ALA ARG TYR GLY LYS VAL PHE ARG GLY ASN SEQRES 14 A 707 LYS VAL LYS ASN ALA GLN LEU ALA GLY ALA LYS GLY VAL SEQRES 15 A 707 ILE LEU TYR SER ASP PRO ALA ASP TYR PHE ALA PRO GLY SEQRES 16 A 707 VAL LYS SER TYR PRO ASP GLY TRP ASN LEU PRO GLY GLY SEQRES 17 A 707 GLY VAL GLN ARG GLY ASN ILE LEU ASN LEU ASN GLY ALA SEQRES 18 A 707 GLY ASP PRO LEU THR PRO GLY TYR PRO ALA ASN GLU TYR SEQRES 19 A 707 ALA TYR ARG ARG GLY ILE ALA GLU ALA VAL GLY LEU PRO SEQRES 20 A 707 SER ILE PRO VAL HIS PRO ILE GLY TYR TYR ASP ALA GLN SEQRES 21 A 707 LYS LEU LEU GLU LYS MET GLY GLY SER ALA PRO PRO ASP SEQRES 22 A 707 SER SER TRP ARG GLY SER LEU LYS VAL PRO TYR ASN VAL SEQRES 23 A 707 GLY PRO GLY PHE THR GLY ASN PHE SER THR GLN LYS VAL SEQRES 24 A 707 LYS MET HIS ILE HIS SER THR ASN GLU VAL THR ARG ILE SEQRES 25 A 707 TYR ASN VAL ILE GLY THR LEU ARG GLY ALA VAL GLU PRO SEQRES 26 A 707 ASP ARG TYR VAL ILE LEU GLY GLY HIS ARG ASP SER TRP SEQRES 27 A 707 VAL PHE GLY GLY ILE ASP PRO GLN SER GLY ALA ALA VAL SEQRES 28 A 707 VAL HIS GLU ILE VAL ARG SER PHE GLY THR LEU LYS LYS SEQRES 29 A 707 GLU GLY TRP ARG PRO ARG ARG THR ILE LEU PHE ALA SER SEQRES 30 A 707 TRP ASP ALA GLU GLU PHE GLY LEU LEU GLY SER THR GLU SEQRES 31 A 707 TRP ALA GLU GLU ASN SER ARG LEU LEU GLN GLU ARG GLY SEQRES 32 A 707 VAL ALA TYR ILE ASN ALA ASP SER SER ILE GLU GLY ASN SEQRES 33 A 707 TYR THR LEU ARG VAL ASP CYS THR PRO LEU MET TYR SER SEQRES 34 A 707 LEU VAL HIS ASN LEU THR LYS GLU LEU LYS SER PRO ASP SEQRES 35 A 707 GLU GLY PHE GLU GLY LYS SER LEU TYR GLU SER TRP THR SEQRES 36 A 707 LYS LYS SER PRO SER PRO GLU PHE SER GLY MET PRO ARG SEQRES 37 A 707 ILE SER LYS LEU GLY SER GLY ASN ASP PHE GLU VAL PHE SEQRES 38 A 707 PHE GLN ARG LEU GLY ILE ALA SER GLY ARG ALA ARG TYR SEQRES 39 A 707 THR LYS ASN TRP GLU THR ASN LYS PHE SER GLY TYR PRO SEQRES 40 A 707 LEU TYR HIS SER VAL TYR GLU THR TYR GLU LEU VAL GLU SEQRES 41 A 707 LYS PHE TYR ASP PRO MET PHE LYS TYR HIS LEU THR VAL SEQRES 42 A 707 ALA GLN VAL ARG GLY GLY MET VAL PHE GLU LEU ALA ASN SEQRES 43 A 707 SER ILE VAL LEU PRO PHE ASP CYS ARG ASP TYR ALA VAL SEQRES 44 A 707 VAL LEU ARG LYS TYR ALA ASP LYS ILE TYR SER ILE SER SEQRES 45 A 707 MET LYS HIS PRO GLN GLU MET LYS THR TYR SER VAL SER SEQRES 46 A 707 PHE ASP SER LEU PHE SER ALA VAL LYS ASN PHE THR GLU SEQRES 47 A 707 ILE ALA SER LYS PHE SER GLU ARG LEU GLN ASP PHE ASP SEQRES 48 A 707 LYS SER ASN PRO ILE VAL LEU ARG MET MET ASN ASP GLN SEQRES 49 A 707 LEU MET PHE LEU GLU ARG ALA PHE ILE ASP PRO LEU GLY SEQRES 50 A 707 LEU PRO ASP ARG PRO PHE TYR ARG HIS VAL ILE TYR ALA SEQRES 51 A 707 PRO SER SER HIS ASN LYS TYR ALA GLY GLU SER PHE PRO SEQRES 52 A 707 GLY ILE TYR ASP ALA LEU PHE ASP ILE GLU SER LYS VAL SEQRES 53 A 707 ASP PRO SER LYS ALA TRP GLY GLU VAL LYS ARG GLN ILE SEQRES 54 A 707 TYR VAL ALA ALA PHE THR VAL GLN ALA ALA ALA GLU THR SEQRES 55 A 707 LEU SER GLU VAL ALA MODRES 2C6P ASN A 76 ASN GLYCOSYLATION SITE MODRES 2C6P ASN A 140 ASN GLYCOSYLATION SITE MODRES 2C6P ASN A 459 ASN GLYCOSYLATION SITE MODRES 2C6P ASN A 476 ASN GLYCOSYLATION SITE MODRES 2C6P ASN A 638 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NAG B 2 14 HET NAG C 1 14 HET NAG C 2 14 HET NAG D 1 14 HET NAG D 2 14 HET BMA D 3 11 HET ZN A1751 1 HET ZN A1752 1 HET CA A1753 1 HET CL A1754 1 HET NAG A1757 14 HET NAG A1758 14 HET PO4 A1764 5 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM ZN ZINC ION HETNAM CA CALCIUM ION HETNAM CL CHLORIDE ION HETNAM PO4 PHOSPHATE ION FORMUL 2 NAG 8(C8 H15 N O6) FORMUL 4 BMA C6 H12 O6 FORMUL 5 ZN 2(ZN 2+) FORMUL 7 CA CA 2+ FORMUL 8 CL CL 1- FORMUL 11 PO4 O4 P 3- FORMUL 12 HOH *87(H2 O) HELIX 1 1 ASN A 57 LEU A 65 1 9 HELIX 2 2 LYS A 66 THR A 78 1 13 HELIX 3 3 THR A 86 GLY A 104 1 19 HELIX 4 4 ARG A 181 ASP A 191 1 11 HELIX 5 5 PHE A 209 ALA A 220 1 12 HELIX 6 6 ASP A 230 PHE A 235 1 6 HELIX 7 7 GLY A 282 ALA A 286 5 5 HELIX 8 8 GLY A 298 LYS A 308 1 11 HELIX 9 9 ASP A 316 ARG A 320 5 5 HELIX 10 10 PRO A 388 GLU A 408 1 21 HELIX 11 11 LEU A 428 ASN A 438 1 11 HELIX 12 12 ASN A 438 ARG A 445 1 8 HELIX 13 13 MET A 470 GLU A 480 1 11 HELIX 14 14 SER A 492 SER A 501 1 10 HELIX 15 15 PHE A 521 ARG A 527 1 7 HELIX 16 16 THR A 558 TYR A 566 1 9 HELIX 17 17 PHE A 570 SER A 590 1 21 HELIX 18 18 CYS A 597 MET A 616 1 20 HELIX 19 19 HIS A 618 SER A 626 1 9 HELIX 20 20 PHE A 629 ASP A 652 1 24 HELIX 21 21 ASN A 657 PHE A 675 1 19 HELIX 22 22 PHE A 705 PHE A 713 1 9 HELIX 23 23 ASP A 714 LYS A 718 5 5 HELIX 24 24 ASP A 720 GLU A 744 1 25 SHEET 1 AA 7 SER A 107 TYR A 119 0 SHEET 2 AA 7 THR A 349 LEU A 362 -1 O THR A 349 N TYR A 119 SHEET 3 AA 7 ARG A 414 TRP A 421 -1 O ILE A 416 N LEU A 362 SHEET 4 AA 7 GLU A 367 HIS A 377 1 O ARG A 370 N THR A 415 SHEET 5 AA 7 GLY A 446 ASN A 451 1 N VAL A 447 O TYR A 371 SHEET 6 AA 7 SER A 532 THR A 538 1 O GLY A 533 N ASN A 451 SHEET 7 AA 7 THR A 461 CYS A 466 -1 O THR A 461 N THR A 538 SHEET 1 AB 3 GLU A 137 ASN A 140 0 SHEET 2 AB 3 TYR A 127 ILE A 131 -1 O ILE A 130 N ILE A 138 SHEET 3 AB 3 LYS A 343 HIS A 345 -1 O LYS A 343 N SER A 129 SHEET 1 AC 2 SER A 162 ALA A 163 0 SHEET 2 AC 2 GLY A 256 ASN A 257 1 O GLY A 256 N ALA A 163 SHEET 1 AD 3 ALA A 203 ARG A 204 0 SHEET 2 AD 3 VAL A 225 TYR A 228 1 O ILE A 226 N ALA A 203 SHEET 3 AD 3 VAL A 294 ILE A 297 1 O HIS A 295 N LEU A 227 LINK ND2 ASN A 76 C1 NAG B 1 1555 1555 1.48 LINK ND2 ASN A 140 C1 NAG A1757 1555 1555 1.45 LINK ND2 ASN A 459 C1 NAG A1758 1555 1555 1.47 LINK ND2 ASN A 476 C1 NAG C 1 1555 1555 1.44 LINK ND2 ASN A 638 C1 NAG D 1 1555 1555 1.45 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.44 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.43 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.44 LINK O4 NAG D 2 C1 BMA D 3 1555 1555 1.45 LINK OG1 THR A 269 CA CA A1753 1555 1555 2.45 LINK O THR A 269 CA CA A1753 1555 1555 2.35 LINK O TYR A 272 CA CA A1753 1555 1555 2.28 LINK NE2 HIS A 377 ZN ZN A1752 1555 1555 2.14 LINK OD2 ASP A 387 ZN ZN A1751 1555 1555 1.88 LINK OD1 ASP A 387 ZN ZN A1752 1555 1555 1.98 LINK OE1 GLU A 425 ZN ZN A1751 1555 1555 2.45 LINK OE2 GLU A 425 ZN ZN A1751 1555 1555 1.82 LINK OE2 GLU A 433 CA CA A1753 1555 1555 2.42 LINK OE1 GLU A 433 CA CA A1753 1555 1555 2.40 LINK OE2 GLU A 436 CA CA A1753 1555 1555 2.33 LINK OD1 ASP A 453 ZN ZN A1752 1555 1555 2.63 LINK OD2 ASP A 453 ZN ZN A1752 1555 1555 2.05 LINK NE2 HIS A 553 ZN ZN A1751 1555 1555 2.09 LINK ZN ZN A1751 O3 PO4 A1764 1555 1555 1.96 LINK ZN ZN A1752 O1 PO4 A1764 1555 1555 1.83 LINK CA CA A1753 O HOH A2011 1555 1555 2.32 CISPEP 1 TYR A 242 PRO A 243 0 2.45 CISPEP 2 GLY A 330 PRO A 331 0 -4.91 CISPEP 3 ASP A 387 PRO A 388 0 0.76 CISPEP 4 PHE A 506 SER A 507 0 5.53 CRYST1 102.573 130.365 159.414 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009749 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007671 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006273 0.00000